Navigation Links
IMBiotechnologies Receives FDA Clearance to Market Occlusin(R) 500 Biodegradable Microspheres in the U.S.
Date:5/11/2010

the U.S. market. We plan to launch OCL 500 with a commercialization partner in the latter half of this year."

About IMBio

IMBio is a privately held Canadian biotechnology company focused on developing medical device products for use in the area of embolotherapy. Lead product, OCL 500 microspheres for the treatment of unresectable/inoperable hypervascularized tumours has received marketing clearance from the FDA in the U.S. Other products in development include rapidly-dissolving, drug-eluting and/or radio-labelled microspheres as well as biodegradable coils and stents for use in aneurysms that are not conducive to treatment with microspheres.

About Embolotherapy

Embolotherapy works by cutting off blood flow to benign and malignant hypervascular tumours. The procedure is performed by injecting agents through a catheter into the blood vessels that feed the target tumour. By selectively blocking blood supply, the deprived tumour is either destroyed or devitalized, resulting in therapeutic benefit. Hypervascular tumours are characterized by having an excessive number of blood vessels. Embolotherapy is a minimally invasive treatment for hypervascular tumours such as liver and kidney cancers as well as uterine fibroids. According to the National Cancer Institute, there are approximately 25,000 Americans with liver and intrahepatic bile duct cancer, and approximately 266,000 with kidney and renal pelvic cancer. Across the U.S., approximately 300,000 hysterectomies and 70,000 myomectomies are performed annually to treat uterine fibroids.

This press release may contain forward-looking statements and predictions. These forward-looking statements, by their nature, necessarily involve risks and uncertainties that could cause actual results to differ materially from those contemplated by the
'/>"/>

SOURCE IMBiotechnologies Ltd
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Aeterna Zentaris Receives Orphan-Drug Designation from the FDA for AEZS-108 in Ovarian Cancer
2. InterMune Receives FDA Complete Response Letter on Esbriet(TM) (Pirfenidone) New Drug Application
3. Smith & Nephew Receives FDA 510k Clearance for a 30-year Knee
4. LS9's UltraClean Diesel™ Receives EPA Registration
5. Drug Safety Firm BioSoteria Receives 2009 Best of Business Award
6. Shire Receives INTUNIV (TM) Paragraph IV Notice Letter From Teva Pharmaceuticals
7. Indiana Collaborative Receives $10.3 Million in Federal Stimulus Funds to Improve Healthcare through Information Technology
8. Advanced Life Sciences Receives FDA Guidance on Approval Pathway for Restanza in Community Acquired Bacterial Pneumonia and Biodefense Indications
9. MedShape Solutions, Inc. Announces Commercialization of SBIR Funded Technology: Receives Purchasing Preference in Federally Funded Hospitals and Health Care Facilities
10. Gems Sensors & Controls Receives ISO-13485:2003 Certification
11. BioMS Medical reports Spectral receives FDA approval to initiate pivotal trial and closes financing for $19.5 million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 27, 2014 Riviera Beach, Florida ... the creation of the Sancilio Scientific Advisory Board ... SCI’s philosophy of looking to nature for pharmaceutical ... actions are based on sound scientific data, analyses, ... Board provides a vehicle for SCI to receive ...
(Date:8/27/2014)... After the boom of the energy ... beverage craze is going to be the stress relief ... use Stress Relief energy pattern which can be applied ... a beverage, including minerals, herbs and liquids. Stress Relief ... power into rapid recovery and helping to adapt more ...
(Date:8/27/2014)... Remcom announces an update to XFdtd® ... the biomedical industry. The central biomedical addition in ... to the Bio-Pro version of the software. XFdtd ... calculate the biological effects of electromagnetic fields. In ... versions to expand engineers’ post-processing options. , The Biological ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Budding ... Cleveland's University School participated in the ... Western Reserve University’s School of Medicine . ... with an unparalleled professional experience in the sciences ... of Medicine faculty and students for both academic ...
Breaking Biology Technology:New Sancilio & Company, Inc. Scientific Board 2New Sancilio & Company, Inc. Scientific Board 3Stress Relief: 1 Way to De-Stress Your Beverage Formula 2Stress Relief: 1 Way to De-Stress Your Beverage Formula 3Stress Relief: 1 Way to De-Stress Your Beverage Formula 4Remcom Announces Enhanced Biological Thermal Sensor and Other Biomedical Features in XFdtd EM Simulation Software Update 2Remcom Announces Enhanced Biological Thermal Sensor and Other Biomedical Features in XFdtd EM Simulation Software Update 3Students at Cleveland's University School Conduct Biomedical Research at Case Western Reserve University’s School of Medicine 2
... "We Want to Double our Sales Within Three Years", ... in,sales of EUR 3.4 million to EUR 17 million, ... the path of significant growth in 2007. "We want ... years," states CEO Nikolaus Uleer.,With the construction of the ...
... 10 Arena Pharmaceuticals,Inc. (Nasdaq: ARNA ) today ... 2007 after the NASDAQ Global Market closes on Wednesday,October ... and,Chief Executive Officer, and Robert E. Hoffman, Arena,s Vice ... call at 5:00,p.m. Eastern Time (2:00 p.m. Pacific Time) ...
... (ED) hold a,critical key in improving acute coronary ... all the tools that you need to improve ... to Better Myocardial,Infarction Outcomes: Emergency Departments Hold the ... experts, Deborah Diercks, MD; James Hoekstra, MD; and,Charles ...
Cached Biology Technology:Dr. Suwelack Skin & Health Care: New Product in the FDA Certification Process 2Arena Pharmaceuticals to Report Third Quarter 2007 Financial Results and to Host Conference Call and Webcast on Wednesday, October 17, 2007 2Arena Pharmaceuticals to Report Third Quarter 2007 Financial Results and to Host Conference Call and Webcast on Wednesday, October 17, 2007 3UPDATE: Free CME-certified Webcast: Opening the Door to Better Myocardial Infarction Outcomes: Emergency Departments Hold the Key 2UPDATE: Free CME-certified Webcast: Opening the Door to Better Myocardial Infarction Outcomes: Emergency Departments Hold the Key 3
(Date:8/27/2014)... that exists as five strains, none of which have ... the Sudan ebolavirus (SUDV). Although not the strain currently ... as recently as 2012. In a new study appearing ... now report a possible therapy that could someday help ... Sidhu, Jonathan Lai and colleagues explain that about 50-90 ...
(Date:8/27/2014)... or abandoned each year in U.S. waters and become ... catch fish, crabs, and other species such as turtles. ... the watermen who depend on the resources--losses that are ... , The report, published in the Marine Pollution ... examine the derelict fish trap problem, and so-called "ghost ...
(Date:8/27/2014)... has shown that piglets can be weaned later with ... outcome of the study at the University,s Roseworthy campus, ... is an important finding for pig producers. It allows ... production. , "Sows don,t usually start their oestrous cycles ... piglets have been weaned," says Ms Alice Weaver, PhD ...
Breaking Biology News(10 mins):Potential therapy for the Sudan strain of Ebola could help contain some future outbreaks 2NOAA's Marine Debris Program reports on the national issue of derelict fishing traps 2Piglet weaning age no bar to litter frequency 2
... The New York Stem Cell Foundation (NYSCF) Research Institute in ... Mount Sinai (ISMMS) successfully generated a stem cell model of ... identified fourteen genes that may be implicated in the disease ... inflammation may play in the brain of Alzheimer,s patients. ...
... 2014)- The leatherback turtle in the Pacific Ocean is one ... has declined by more than 90 percent since 1980. One ... set thousands of hooks in the ocean to catch fish, ... technology, researchers are now able to predict where fisheries and ...
... with a heart defect such as a hole in the heart, ... quickly and safely secure devices inside the heart. Sutures take too ... tissue, and currently available clinical adhesives are either too toxic or ... or under dynamic conditions, such as in a beating heart. ...
Cached Biology News:Stem cell research identifies new gene targets in patients with Alzheimer's disease 2Stem cell research identifies new gene targets in patients with Alzheimer's disease 3GPS traffic maps for leatherback turtles show hotspots to prevent accidental fishing deaths 2GPS traffic maps for leatherback turtles show hotspots to prevent accidental fishing deaths 3Bio-inspired glue keeps hearts securely sealed 2Bio-inspired glue keeps hearts securely sealed 3
assays for phosphatase, lipase, nucleoside triphosphatases (ATPase, GTPase etc). HTS and follow up studies for phosphatase inhibitors. Quantitation of phosphate content in protein, lipids, and DNA....
EnzChek cellulase substrate *blue fluorescent, 339/452...
... Kb RNA Ladder is suitable for sizing single-stranded RNA ... or formaldehyde agarose gels. The ladder consists of nine ... 4 6 8 and 10 kb) to simplify size ... the other bands allowing easy orientation and identification of ...
...
Biology Products: